Vital Therapies lowers the bar in its 2nd try at an initial public offering, aiming to raise up to $68 million this time around.
Bio-artificial liver maker Vital Therapies set the range for its initial public offering at $13 to $15 per share, below the $16 to $18 range it set last year before scuttling its 1st try at a U.S. IPO.
In March Vital Therapies filed updated registration statements signaling its intent to launch the IPO, wiping clean the pricing set in November 2013. Another filing today set the new price range for the 4.5-million-share offering at $58.5 million to $67.5 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1hkYHGN
Cap comentari:
Publica un comentari a l'entrada